APA (7th ed.) Citation

Ostrowska-Leśko, M., Mądry, R., & Bobiński, M. (2025). Optimizing bevacizumab dosing in first-line ovarian cancer treatment: The PGOG-ov1 trial. Trials, 26(1), 1. https://doi.org/10.1186/s13063-025-09062-8

Chicago Style (17th ed.) Citation

Ostrowska-Leśko, Marta, Radosław Mądry, and Marcin Bobiński. "Optimizing Bevacizumab Dosing in First-line Ovarian Cancer Treatment: The PGOG-ov1 Trial." Trials 26, no. 1 (2025): 1. https://doi.org/10.1186/s13063-025-09062-8.

MLA (9th ed.) Citation

Ostrowska-Leśko, Marta, et al. "Optimizing Bevacizumab Dosing in First-line Ovarian Cancer Treatment: The PGOG-ov1 Trial." Trials, vol. 26, no. 1, 2025, p. 1, https://doi.org/10.1186/s13063-025-09062-8.